246 related articles for article (PubMed ID: 34003380)
41. Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4.
De Logu F; Trevisan G; Marone IM; Coppi E; Padilha Dalenogare D; Titiz M; Marini M; Landini L; Souza Monteiro de Araujo D; Li Puma S; Materazzi S; De Siena G; Geppetti P; Nassini R
BMC Biol; 2020 Dec; 18(1):197. PubMed ID: 33317522
[TBL] [Abstract][Full Text] [Related]
42. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
[TBL] [Abstract][Full Text] [Related]
43. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
44. Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
Chen YF; Chen LH; Yeh YM; Wu PY; Chen YF; Chang LY; Chang JY; Shen MR
Sci Rep; 2017 Mar; 7():45366. PubMed ID: 28349969
[TBL] [Abstract][Full Text] [Related]
45. Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy.
Adamek P; Heles M; Palecek J
Neuropharmacology; 2019 Mar; 146():163-174. PubMed ID: 30471295
[TBL] [Abstract][Full Text] [Related]
46. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M; Imai S; Matsumoto M; Iguma Y; Kawaguchi-Sakita N; Kotake T; Iwamitsu Y; Ntogwa M; Hiraiwa R; Nagayasu K; Saigo M; Ogihara T; Yonezawa A; Omura T; Nakagawa S; Nakagawa T; Matsubara K
Cancer Res; 2021 Apr; 81(8):2207-2219. PubMed ID: 33608316
[TBL] [Abstract][Full Text] [Related]
47. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.
Laumet G; Edralin JD; Dantzer R; Heijnen CJ; Kavelaars A
Pain; 2019 Jun; 160(6):1459-1468. PubMed ID: 30720585
[TBL] [Abstract][Full Text] [Related]
48. Interaction of the synthetic cannabinoid WIN55212 with tramadol on nociceptive thresholds and core body temperature in a chemotherapy-induced peripheral neuropathy pain model.
Haddad M; Alsalem M; Saleh T; Jaffal SM; Barakat NA; El-Salem K
Neuroreport; 2023 May; 34(8):441-448. PubMed ID: 37096753
[TBL] [Abstract][Full Text] [Related]
49. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.
Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y
J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478
[TBL] [Abstract][Full Text] [Related]
50.
Kuai CP; Ju LJ; Hu PP; Huang F
Am J Chin Med; 2020; 48(2):407-428. PubMed ID: 32138533
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy-induced peripheral neuropathy among patients with ovarian cancer.
Jin L; Zhang Y; Yang W
Int J Gynaecol Obstet; 2020 Jun; 149(3):303-308. PubMed ID: 32133643
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.
Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D
Support Care Cancer; 2019 Dec; 27(12):4771-4777. PubMed ID: 30972648
[TBL] [Abstract][Full Text] [Related]
53. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
54. Expression profiles of TRPV1, TRPV4, TLR4 and ERK1/2 in the dorsal root ganglionic neurons of a cancer-induced neuropathy rat model.
Maqboul A; Elsadek B
PeerJ; 2018; 6():e4622. PubMed ID: 29637027
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
Resham K; Sharma SS
Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
[TBL] [Abstract][Full Text] [Related]
56. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain.
Li Y; Cai J; Han Y; Xiao X; Meng XL; Su L; Liu FY; Xing GG; Wan Y
Eur J Pain; 2014 Jul; 18(6):774-84. PubMed ID: 24827675
[TBL] [Abstract][Full Text] [Related]
57. Probing for chemotherapy-induced peripheral neuropathy in live dorsal root ganglion neurons with atomic force microscopy.
Au NP; Fang Y; Xi N; Lai KW; Ma CH
Nanomedicine; 2014 Aug; 10(6):1323-33. PubMed ID: 24632247
[TBL] [Abstract][Full Text] [Related]
58. Advances in Spinal Neuromodulation for Chemotherapy-induced Peripheral Neuropathy.
Gupta P; Patel K; Paul G
Anticancer Res; 2024 Jul; 44(7):2769-2774. PubMed ID: 38925845
[TBL] [Abstract][Full Text] [Related]
59. Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy.
Chen LH; Yeh YM; Chen YF; Hsu YH; Wang HH; Lin PC; Chang LY; Lin CK; Chang MS; Shen MR
Pain; 2020 Jun; 161(6):1237-1254. PubMed ID: 32068666
[TBL] [Abstract][Full Text] [Related]
60. TRPV1 receptors contribute to paclitaxel-induced c-Fos expression in spinal cord dorsal horn neurons.
Kalynovska N; Adamek P; Palecek J
Physiol Res; 2017 Jul; 66(3):549-552. PubMed ID: 28730839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
